Diamond Biofund Profit Margin

Diamond Biofund's profit margin stands at 227.8% as of March 2026. That compares with 114.01% in the prior-year period — up 99.8% year over year. That is above the sector sector average of 13.16%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Diamond Biofund reported 227.8% in profit margin versus 114.01% a year earlier — a 99.8% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Diamond Biofund sits higher the its sector benchmark (13.16%) with a profit margin of 227.8%. That is roughly 1630.5% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 227.8% for Diamond Biofund means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Diamond Biofund's profit margin evolved across reporting periods, while the comparison chart places 6901.TWO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.